INVO Bioscience, Inc. (NASDAQ:INVO) Q2 2022 Earnings Conference Call August 15, 2022 4:30 PM ET
Company Participants
Robert Blum – Investor Relations
Steve Shum – Chief Executive Officer
Mike Campbell – Chief Operating Officer and Vice President of Business Development
Andrea Goren – Chief Financial Officer
Conference Call Participants
John Heerdink – Vista Partners LLC
Curtis Thom – Paulson
Operator
Good day, and welcome to the INVO Bioscience's Reports Second Quarter 2022 Financial Results Call. All participants will be in listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. Please note this event is being recorded.
I would now like to turn the conference over to Robert Blum. Please go ahead.
Robert Blum
Hi. Thank you very much. Good afternoon everyone and thank you for joining us today to discuss INVO Bioscience's second quarter 2022 financial results. Joining us on today's call is INVO Bioscience's CEO, Steve Shum; the Company's Chief Operating Officer and VP of Business Development, Mike Campbell; and Andrea Goren, the Company's Chief Financial Officer. At the conclusion of today's prepared remarks, we will open the call for a question-and-answer session.
Before we begin the event, we submit for the record the following statement. Certain matters discussed on this conference call by the management of INVO Bioscience, may be forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended, Section 21E of the Securities Exchange Act of 1934 as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
All statements regarding the Company's expected future financial position, results of operations, cash flows, financing plans, business strategies, products and services, competitive positions, growth opportunities, plans and objections – objectives of management for future operations, as well as statements that include words such as anticipate, if, believe, plan, estimate, expect, intend, may, could, should, will, and other similar expressions are forward-looking statements.
All forward-looking statements involve risks and uncertainties, and contingencies, many of which are beyond the company's control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance or achievements. Factors that may cause actual results to differ materially from those in the forward-looking statements include those set forth in the company's filings, at www.sec.gov. Company is under no obligation to and expressly disclaims any such obligation to update or alter our forward-looking statements, whether the result of new information, future events or otherwise.